Penn Medicine

Penn Medicine is a research institution that focuses on medical innovation and patient care. They offer a variety of services including CAR T cell therapy for brain tumors and studies on the causes of long COVID.

79%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

85%

Examples:

  • The article mentions that CAR T cell therapy has shown promise in reducing solid tumor growth for GBM patients but only six patients were treated and results have not been replicated. This is an example of deceptive language as it implies success without providing evidence.

Conflicts of Interest

100%

Examples:

  • The Penn Medicine article mentions a technology developed in the lab of Donald M. O'Rourke, MD to deliver CAR T cells targeting two proteins commonly found in brain tumors: epidermal growth factor receptor (EGFR) and interleukin-13 receptor alpha 2 (IL13Rα2). This is a clear conflict of interest as the researcher has a financial stake in the technology being used.

Contradictions

60%

Examples:

  • The Penn Medicine article suggests that long COVID is caused by a decrease in serotonin levels. However, both the NBC Right Now and Daily Mail articles contradict this by suggesting that long COVID is caused by remnants of the virus in the gut.

Deceptions

50%

Examples:

  • The article mentions that CAR T cell therapy has shown promise in reducing solid tumor growth for GBM patients but only six patients were treated and results have not been replicated. This is an example of deceptive language as it implies success without providing evidence.

Recent Articles

  • Promising Breakthrough in Glioblastoma Treatment with CAR T Cells: Early Hints of Progress from Two Preliminary Studies

    Promising Breakthrough in Glioblastoma Treatment with CAR T Cells: Early Hints of Progress from Two Preliminary Studies

    Broke On: Thursday, 14 March 2024 Two studies show promise of CAR T cells against glioblastoma, a deadly brain cancer. The engineered immune cells target two proteins found in the tumor and may extend survival.

  • Serotonin Reduction Linked to Long COVID Symptoms, Suggests Penn Study

    Broke On: Monday, 16 October 2023 A study by the University of Pennsylvania suggests that a reduction in serotonin could be the cause of Long COVID symptoms. The SARS-CoV-2 virus can remain in the gut for an extended period, disrupting the production of serotonin.